Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuele D'Amico

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
Multiple Sclerosis and Related Disorders|June 3, 2019
Review: Patient-reported outcomes in multiple sclerosis careEmanuele D'Amico, Rocco Haase, Tjalf Ziemssen
Neural Regeneration Research|August 12, 2021
Injectable <i>versus</i> oral first-line multiple sclerosis therapies: knows and unknowns from observational studiesEmanuele D'Amico, Aurora Zanghì, Carlo Avolio
Functional Neurology|March 31, 2016
Disability may influence patient willingness to participate in decision making on first-line therapy in multiple sclerosisEmanuele D'Amico, Carmela Leone, Francesco Patti
International Journal of Molecular Sciences|February 25, 2016
Offspring Number Does Not Influence Reaching the Disability's Milestones in Multiple Sclerosis: A Seven-Year Follow-Up StudyEmanuele D'Amico, Carmela Leone, Francesco Patti
Expert Opinion on Pharmacotherapy|August 23, 2017
Induction therapy for the management of early relapsing forms of multiple sclerosis. A critical opinionEmanuele D'Amico, Tjalf Ziemssen, Salvatore Cottone
Expert Review of Neurotherapeutics|January 24, 2020
Immunosuppression in relapsing remitting multiple sclerosis: moving towards personalized treatmentAurora Zanghì, Emanuele D'Amico, Francesco Patti
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 19, 2010
Treatment options of cognitive impairment in multiple sclerosisFrancesco Patti, Carmela Leone, Emanuele D'Amico
Expert Opinion on Pharmacotherapy|December 1, 2016
Can new chemical therapies improve the management of multiple sclerosis in children?Emanuele D'Amico, Aurora Zanghì, Francesco Patti
Expert Review of Neurotherapeutics|February 25, 2015
Monoclonal antibody therapy in multiple sclerosis: critical appraisal and new perspectivesEmanuele D'Amico, Cinzia Caserta, Francesco Patti
Expert Review of Neurotherapeutics|June 9, 2017
To stop or not to stop disease modifying therapies in secondary progressive multiple sclerosis, that is the questionEmanuele D'Amico, Tjalf Ziemssen, Salvatore Cottone
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
Multiple Sclerosis and Related Disorders|June 3, 2019
Review: Patient-reported outcomes in multiple sclerosis careEmanuele D'Amico, Rocco Haase, Tjalf Ziemssen
Neural Regeneration Research|August 12, 2021
Injectable <i>versus</i> oral first-line multiple sclerosis therapies: knows and unknowns from observational studiesEmanuele D'Amico, Aurora Zanghì, Carlo Avolio
Functional Neurology|March 31, 2016
Disability may influence patient willingness to participate in decision making on first-line therapy in multiple sclerosisEmanuele D'Amico, Carmela Leone, Francesco Patti
International Journal of Molecular Sciences|February 25, 2016
Offspring Number Does Not Influence Reaching the Disability's Milestones in Multiple Sclerosis: A Seven-Year Follow-Up StudyEmanuele D'Amico, Carmela Leone, Francesco Patti
Expert Opinion on Pharmacotherapy|August 23, 2017
Induction therapy for the management of early relapsing forms of multiple sclerosis. A critical opinionEmanuele D'Amico, Tjalf Ziemssen, Salvatore Cottone
Expert Review of Neurotherapeutics|January 24, 2020
Immunosuppression in relapsing remitting multiple sclerosis: moving towards personalized treatmentAurora Zanghì, Emanuele D'Amico, Francesco Patti
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 19, 2010
Treatment options of cognitive impairment in multiple sclerosisFrancesco Patti, Carmela Leone, Emanuele D'Amico
Expert Opinion on Pharmacotherapy|December 1, 2016
Can new chemical therapies improve the management of multiple sclerosis in children?Emanuele D'Amico, Aurora Zanghì, Francesco Patti
Expert Review of Neurotherapeutics|February 25, 2015
Monoclonal antibody therapy in multiple sclerosis: critical appraisal and new perspectivesEmanuele D'Amico, Cinzia Caserta, Francesco Patti
Expert Review of Neurotherapeutics|June 9, 2017
To stop or not to stop disease modifying therapies in secondary progressive multiple sclerosis, that is the questionEmanuele D'Amico, Tjalf Ziemssen, Salvatore Cottone
Pageof 12